Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
about
Regulation of adaptive immunity; the role of interleukin-10European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsDefects in mucosal immunity leading to Crohn's diseaseRecombinant human interleukin 10 for induction of remission in Crohn's diseaseCurrent stage in inflammatory bowel disease: What is next?The relationship between the immune system and oral manifestations of inflammatory bowel disease: a reviewRegulatory T cells in multiple sclerosis and myasthenia gravis.Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.Medical management of Crohn's disease.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis.3D domain swapping causes extensive multimerisation of human interleukin-10 when expressed in planta.New developments in the treatment of inflammatory bowel disease.Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis.Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.Review article: biological agents in the treatment of Crohn's disease.Gene transfer approaches for the treatment of inflammatory bowel disease.Risk of postoperative recurrence and postoperative management of Crohn's diseaseInterleukin-10-based therapy for inflammatory bowel disease.Small-molecule control of cytokine function: new opportunities for treating immune disordersAn interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.IL-10 and its related cytokines for treatment of inflammatory bowel disease.Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.Novel biological strategies in inflammatory bowel diseases.Biologics in inflammatory bowel disease: how much progress have we made?Management of ulcerative colitis and Crohn's disease.Treatment of postoperative Crohn's disease.Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.Future therapeutic options for celiac disease.Radiation damage and radioprotectants: new concepts in the era of molecular medicineEvolving knowledge and therapy of inflammatory bowel disease.Interleukin-10 and chronic liver diseaseInterleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.Review article: can post-operative recurrence in Crohn's disease be prevented?How to modulate inflammatory cytokines in liver diseases.Probiotics: properties, examples, and specific applications.Safety of biologic therapy.Maintenance of surgically induced remission of Crohn's disease.Management of postoperative Crohn's disease.Postoperative Crohn's disease recurrence: a practical approach
P2860
Q21131215-0B4B740D-A920-4A68-8DEF-91BFAC04D280Q22242050-F53FACA5-7703-4850-8CA2-6716E7F7552FQ22242645-E1454EE5-83EE-439C-B129-36249142EE5EQ24236636-5485290D-05BA-415B-B965-DAD021D64FFAQ26777429-91E120C1-940E-4937-9FD8-7BB606DC4A45Q28078219-F263E0D9-2E71-4EA2-AE1A-D3616A129595Q33784969-0D175A6F-15AE-4DCB-8F28-E0475797163DQ34030833-6323D42A-5B14-44CD-9A59-3F6FA9F73B0BQ34046139-ABE9581F-66DA-493E-9732-AEDB20BCFAB8Q34152778-167BBB4D-8A0F-4289-ADD7-DA52D5FC8F26Q34218443-BB028C1A-22F4-43AC-A8A2-DCF99B0AF994Q34437671-3A8B39FD-AFC3-457F-94AA-1B97FBA87D02Q34544666-FFD455C4-A576-48CD-BA62-3A0E7EDDBA81Q34669243-FC252520-FF45-4BCB-B588-0F76511A2136Q34789021-F7D39900-82AC-4702-B41B-AE29AA4E8844Q34799343-65B3E65F-4062-45D3-9ABB-D07BC216F75DQ35122162-6276F7C1-9F53-4760-A017-C27A88652CD7Q35171537-D2395A47-F545-4AA5-9E33-984CA75895B4Q35184708-1C91E760-0ADB-4AD6-8D7F-2353C010D0AFQ35252669-F7BBD0BD-DEF7-4181-B2F0-DBFC685D1C66Q35596317-19527B2E-B2A8-44BF-A19B-2479F8151B0EQ35678651-7E2070C8-9D0D-4242-8775-E9FB8149BC59Q35680472-8BAF011F-E00A-4320-9FD5-39C2B6824FB3Q35787653-5678976F-C8EC-4C2A-97ED-ED6406E000CAQ35861158-2C7C7F80-1412-44C6-A3DC-6F22C70716DAQ36004867-1ED95070-5A41-40F8-8DA2-9F92F143373CQ36041737-466DFB28-4A24-4D92-B664-EDF0860A92D9Q36131710-0C417C30-F46E-4348-AF66-D633B7002080Q36304110-D76874FF-0487-45B1-8AED-0D5D5009E125Q36364394-C74C7E51-C87A-4D3C-A8CB-F80034FA3565Q36414506-A61F4454-2B7D-4475-B753-866A1FEB7FB1Q36439804-D82E79E2-BC8C-47E6-B316-83991AC76E12Q36543665-B22E2E37-CA07-4CF9-8B5A-B7FD279C4461Q36589399-E188245A-82E4-40A7-86EA-8FBD5AE51852Q36619707-DD2F0CBE-953A-4EC0-B2C7-EB25A2C8389FQ36629073-776EA685-A57E-4EAE-B528-D9002913C91EQ36737339-868F7381-4CF8-45C2-A1D8-CC60BF64B23FQ37073415-C5ADE86D-1834-4D42-B236-906F2AB32FD3Q37120949-6B84C8ED-F677-405D-B0DA-3BD0E310F93FQ37276985-9BFFE93F-ED68-4F65-B112-2B7B3F0015F8
P2860
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
@ast
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
@en
type
label
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
@ast
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
@en
prefLabel
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
@ast
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
@en
P2093
P2860
P50
P356
P1433
P1476
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
@en
P2093
A Ferguson
J F Colombel
J Rask-Madsen
P Rutgeerts
S Van Deventer
P2860
P356
10.1136/GUT.49.1.42
P407
P577
2001-07-01T00:00:00Z